Exemestane
-
Molecular Structure
Detailed Description
IUPAC NAME-6-Methylideneandrosta-1,4-diene-3,17-dione[1]
MOLECULAR FORMULA-C20H24O2
MOLAR MASS-296.403 g/mol
Exemestane is indicated for the adjuvant treatment of postmenopausal women with estrogen-receptor positive early breast cancer who have received two to three years of tamoxifen and are switched to it for completion of a total of five consecutive years of adjuvant hormonal therapy

- Exemestane